Vycor Medical (VYCO) Operating Expenses (2010 - 2026)

Vycor Medical (VYCO) has 17 years of Operating Expenses data on file, last reported at $329345.0 in Q1 2026.

• On a quarterly basis, Operating Expenses fell 11.31% year-over-year to $329345.0 in Q1 2026; TTM through Mar 2026 was $1.5 million, a 0.56% decrease from a year earlier, with the FY2025 full-year figure at $1.5 million, up 6.67% from the prior year.
• Operating Expenses for Q1 2026 stood at $329345.0, down from $371895.0 in the prior quarter.
• Over the last five years, Operating Expenses for VYCO reached as high as $419847.0 in Q3 2025 and fell as low as $296987.0 in Q1 2023.
• Historically, Operating Expenses has averaged $350149.1 across 5 years, with a median of $354937.0 in 2024.
• Across the five-year window, Operating Expenses declined 29.7% in 2022 and increased 28.98% in 2024, its largest moves.
• Year by year, Operating Expenses stood at $325309.0 in 2022, then grew by 1.53% to $330285.0 in 2023, then rose by 14.46% to $378038.0 in 2024, then slipped by 1.62% to $371895.0 in 2025, then fell by 11.44% to $329345.0 in 2026.
• Per Business Quant data, the three most recent Operating Expenses figures were $329345.0 in Q1 2026, $371895.0 in Q4 2025, and $419847.0 in Q3 2025.